X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Hannah Mooney Mack

Hannah Mooney Mack Hannah is a former Director of Public Affairs at PhRMA, managing the creative development and design of PhRMA-branded campaigns through paid, earned, and digital/social campaigns.

Recent Posts

PPA celebrates 13 years of helping patients access their medicines

By Hannah Mooney Mack  |    April 5, 2018
As of 2018, 13 is no longer an unlucky number, especially when it comes to health. This April, the Partnership for Prescription Assistance (PPA) is celebrating 13 years of connecting people who are...   Read More

2017 Research & Hope Awards honor innovators in mental health

By Hannah Mooney Mack  |    October 10, 2017
Mental health disorders are a heavy human and economic burden in the United States. More than 40 million people across the country are impacted by mental illness, and it’s estimated that in any given...   Read More

12 years of the Partnership of Prescription Assistance

By Hannah Mooney Mack  |    April 5, 2017
Today, the Partnership for Prescription Assistance (PPA) is celebrating 12 years of helping connect patients who struggle with affordable access to the medicines they need. Because PPA serves as a...   Read More

PPA: 2016 in review

By Hannah Mooney Mack  |    February 23, 2017
More than a decade has passed since the Partnership for Prescription Assistance (PPA) launched. In this time, PPA has helped nearly 10 million patients through its free and confidential program, but...   Read More

New PhRMA report: More than 170 medicines in development for diabetes offer patients longer, healthier lives

By Hannah Mooney Mack  |    November 14, 2016
Today, there are more than 30 million Americans suffering from type 1 or type 2 diabetes. Roughly 5 percent of patients have type 1 and 90 to 95 percent suffer from type 2, highlighting the...   Read More

Eradication of measles highlights the promise of vaccines in development

By Hannah Mooney Mack  |    September 29, 2016
On September 27, the Pan American Health Organization (PAHO) alongside the World Health Organization (WHO) announced that the Region of the Americas is the first region in the world to have...   Read More

Celebrating hope for patients and families on World Heart Day 2016

By Hannah Mooney Mack  |    September 29, 2016
My heart lives in Portland, Ore. The reason I do my work is there too. That’s where I grew up and where I saw my grandfather earlier this month. If you ask him how he is doing, he’ll say, “I’m doing...   Read More

New PhRMA report: New medicines in development for autoimmune diseases offer patients hope for brighter futures

By Hannah Mooney Mack  |    September 12, 2016
Currently, more than 23.5 million Americans are affected by one of the more than 80 autoimmune diseases identified to date. These diseases range in severity, with their own characteristics and their...   Read More

New report highlights more than 250 vaccines in development

By Hannah Mooney Mack  |    August 18, 2016
More than 200 years ago, the first vaccine was developed for smallpox, and now, the disease has been eradicated worldwide. And in the United States, the transmission of poliovirus, measles and...   Read More

Focusing on patients and progress on World Hepatitis Day

By Hannah Mooney Mack  |    July 28, 2016
World Hepatitis Day is a unique opportunity to take stock of the recent advancements in new treatments and cures to combat versions of hepatitis. Founded by the World Hepatitis Alliance, World...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates